Alzheimer Disease & Dementia
03.21.25
Copy Link
Like
Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neuroscientist focused on understanding AD-related changes in the brain, details his research into the use of plasma p-tau217 as a blood-based biomarker for detecting Alzheimer disease.
Sign up to receive alerts and updates from The Neurology Hub.
Thanks for subscribing
Do you have cases, images, or other information to share? The Neurology Hub welcomes submissions from clinicians and researchers at all levels.
Contribute Here